Abstract:Identifying regulatory modules between miRNAs and genes is crucial in cancer research. It promotes a comprehensive understanding of the molecular mechanisms of cancer. The genomic data collected from subjects usually relate to different cancer statuses, such as different TNM Classifications of Malignant Tumors (TNM) or histological subtypes. Simple integrated analyses generally identify the core of the tumorigenesis (common modules) but miss the subtype-specific regulatory mechanisms (specific modules). In contrast, separate analyses can only report the differences and ignore important common modules. Therefore, there is an urgent need to develop a novel method to jointly analyze miRNA and gene data of different cancer statuses to identify common and specific modules. To that end, we developed a <underline xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H igh- <underline xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">O rder <underline xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">G raph <underline xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">M atching model to identify <underline xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">C ommon and <underline xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">S pecific modules (HOGMCS) between miRNA and gene data of different cancer statuses. We first demonstrate the superiority of HOGMCS through a comparison with four state-of-the-art techniques using a set of simulated data. Then, we apply HOGMCS on stomach adenocarcinoma data with four TNM stages and two histological types, and breast invasive carcinoma data with four PAM50 subtypes. The experimental results demonstrate that HOGMCS can accurately extract common and subtype-specific miRNA-gene regulatory modules, where many identified miRNA–gene interactions have been confirmed in several public databases.

HOGMMNC: A higher order graph matching with multiple network constraints model for gene-drug regulatory modules identification.

Identify Multiple Gene-Drug Common Modules via Constrained Graph Matching

Identification of Multidimensional Regulatory Modules Through Multi-Graph Matching with Network Constraints.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Evaluation of gene-drug common module identification methods using pharmacogenomics data

DM-MOGA: a multi-objective optimization genetic algorithm for identifying disease modules of non-small cell lung cancer

Identifying miRNA-Gene Common and Specific Regulatory Modules for Cancer Subtyping by a High-Order Graph Matching Model

Identifying “Many-to-many” Relationships Between Gene-Expression Data and Drug-Response Data Via Sparse Binary Matching

Deepgmd: A Graph-Neural-Network-Based Method to Detect Gene Regulator Module

MODIG: Integrating Multi-Omics and Multi-Dimensional Gene Network for Cancer Driver Gene Identification Based on Graph Attention Network Model.

MDMNI-DGD: A novel graph neural network approach for druggable gene discovery based on the integration of multi-omics data and the multi-view network

Multiple Networks Modules Identification by a Multi-Dimensional Markov Chain Method

Heterogenous Biological Network Multi-Task Learning Model for Ncrna-Disease-drug Association Prediction

AutoGGN: A Gene Graph Network AutoML Tool for Multi-Omics Research

Integrating data and knowledge to identify functional modules of genes: a multilayer approach

Kinome-wide polypharmacology profiling of small molecules by multi-task graph isomorphism network approach

MiMod: A New Algorithm for Mining Biological Network Modules.

DPADM: a Novel Algorithm for Detecting Drug-Pathway Associations Based on High-Throughput Transcriptional Response to Compounds.

Multiplex Networks and Pan-Cancer Multiomics-Based Driver Gene Identification Using Graph Neural Networks

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

Integration of multi-source gene interaction networks and omics data with graph attention networks to identify novel disease genes